Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies

Bergeri, Isabel; Whelan, Mairead; Ware, Harriet; Subissi, Lorenzo; Nardone, Anthony; C. Lewis, Hannah; Li, Zihan; Ma, Xiaomeng; Valenciano, Marta; Cheng, Brianna; Al Ariqi, Lubna; Rashidian, Arash; Okeibunor, Joseph; Azim, Tasnim; Ranjan Wijesinghe, Pushpa; Le, Linh‐Vi; Vaughan, Aisling; Pebody, Richard; Vicari, Andrea; Yan, Tingting; Yanes‐Lane, Mercedes; Cao, Christian; A. Clifton, David; P. Cheng, Matthew; Papenburg, Jesse; L. Buckeridge, David; Bobrovitz, Niklas; K. Arora, Rahul; D. Van Kerkhove, Maria; Studies Collaborator Group, Unity

doi:10.1371/journal.pmed.1004107

Public

Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies

Published in PLoS Medicine • Nov 10, 2022

Authors:

Isabel Bergeri

Mairead Whelan

Harriet Ware

Abstract

BACKGROUND: Our understanding of the global scale of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection remains incomplete: Routine surveillance data underestimate infection and cannot infer on population immunity; there is a predominance of asymptomatic infections, and uneven ac...

Subject

Seroprevalence

Medicine

Population

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!